TELA Bio, Inc. (TELA)
NASDAQ: TELA · Real-Time Price · USD
0.8200
+0.0390 (4.99%)
Sep 4, 2026, 12:24 PM EDT - Market open
TELA Bio Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 79.91 | 80.28 | 69.3 | 58.45 | 41.42 | 29.46 | |
Revenue Growth | 6.09% | 15.84% | 18.56% | 41.13% | 40.58% | 61.77% |
Cost of Revenue | 25.34 | 25.55 | 22.43 | 17.96 | 13.57 | 10.35 |
Gross Profit | 54.57 | 54.72 | 46.87 | 40.49 | 27.85 | 19.12 |
Selling, General & Admin | 78.66 | 78.88 | 79.37 | 74.57 | 57.11 | 41.52 |
Research & Development | 9.54 | 9.22 | 8.81 | 9.62 | 8.94 | 6.74 |
Amortization of Goodwill & Intangibles | 0.38 | 0.38 | 0.38 | 0.38 | 0.8 | 0.3 |
Operating Expenses | 88.58 | 88.48 | 88.56 | 84.57 | 66.86 | 48.57 |
Operating Income | -34.01 | -33.76 | -41.7 | -44.08 | -39.01 | -29.45 |
Interest Expense | -6.97 | -5.25 | -5.29 | -5.22 | -4.05 | -3.6 |
Other Non Operating Income (Expenses) | 0.95 | 1.29 | 1.42 | 2.63 | -0.01 | -0.23 |
EBT Excluding Unusual Items | -40.03 | -37.71 | -45.57 | -46.66 | -43.07 | -33.28 |
Gain (Loss) on Sale of Assets | - | - | 7.58 | - | - | - |
Other Unusual Items | -0.89 | -0.89 | - | - | -1.23 | - |
Pretax Income | -40.91 | -38.6 | -37.99 | -46.66 | -44.3 | -33.28 |
Income Tax Expense | 0.27 | 0.23 | -0.14 | - | - | - |
Net Income | -41.18 | -38.83 | -37.84 | -46.66 | -44.3 | -33.28 |
Net Income to Common | -41.18 | -38.83 | -37.84 | -46.66 | -44.3 | -33.28 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 53 | 47 | 29 | 23 | 16 | 14 |
Shares Outstanding (Diluted) | 53 | 47 | 29 | 23 | 16 | 14 |
Shares Change | 36.23% | 64.58% | 24.74% | 40.58% | 12.40% | 11.90% |
EPS (Basic) | -0.78 | -0.83 | -1.33 | -2.04 | -2.72 | -2.30 |
EPS (Diluted) | -0.78 | -0.83 | -1.33 | -2.04 | -2.72 | -2.30 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -31.62 | -28.67 | -42.58 | -41.47 | -41.62 | -31.06 |
Free Cash Flow Per Share | -0.60 | -0.61 | -1.49 | -1.81 | -2.56 | -2.15 |
Gross Margin | 68.29% | 68.17% | 67.63% | 69.27% | 67.24% | 64.89% |
Operating Margin | -42.56% | -42.05% | -60.17% | -75.40% | -94.18% | -99.96% |
Profit Margin | -51.53% | -48.37% | -54.61% | -79.83% | -106.95% | -112.94% |
Free Cash Flow Margin | -39.57% | -35.71% | -61.45% | -70.94% | -100.49% | -105.42% |
EBITDA | -33.01 | -32.75 | -40.68 | -43.27 | -37.82 | -28.92 |
EBITDA Margin | -41.31% | -40.79% | -58.71% | -74.02% | -91.31% | -98.14% |
D&A For EBITDA | 1 | 1.01 | 1.01 | 0.81 | 1.19 | 0.54 |
EBIT | -34.01 | -33.76 | -41.7 | -44.08 | -39.01 | -29.45 |
EBIT Margin | -42.56% | -42.05% | -60.17% | -75.40% | -94.18% | -99.96% |